Macheon AI
San Francisco · Founded 2024
About Macheon AI
Macheon AI is redefining surgical robotics by commercializing a clinically validated platform developed at Johns Hopkins University by Dr. Russell Taylor’s LCSR group. Our intelligent robotic assistant is designed for high-risk, underserved procedures in skull base, spine, and otolaryngology. Backed by published research, cadaver validation, and initial FDA clearance, Macheon is positioned to lead the next era of precision surgery. With a software-first architecture, real-time AI, and micro-robotic fidelity, we offer investors a rare opportunity: to back a mature, de-risked platform ready for first-in-human trials and accelerated market entry. We are raising a $6M seed round to fuel clinical deployment and scale our commercialization efforts.
Company Facts
- Founded: 2024
- Legal name: Macheon Corporation
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Seed (May 2025)
- Website: macheon.ai
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/macheon-ai-8323820 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.